266 related articles for article (PubMed ID: 30166419)
1. Systematic Analysis of Compounds Specifically Targeting Telomeres and Telomerase for Clinical Implications in Cancer Therapy.
Lee HS; Carmena M; Liskovykh M; Peat E; Kim JH; Oshimura M; Masumoto H; Teulade-Fichou MP; Pommier Y; Earnshaw WC; Larionov V; Kouprina N
Cancer Res; 2018 Nov; 78(21):6282-6296. PubMed ID: 30166419
[TBL] [Abstract][Full Text] [Related]
2. Terpyridine platinum compounds induce telomere dysfunction and chromosome instability in cancer cells.
Petrov N; Lee HS; Liskovykh M; Teulade-Fichou MP; Masumoto H; Earnshaw WC; Pommier Y; Larionov V; Kouprina N
Oncotarget; 2021 Jul; 12(15):1444-1456. PubMed ID: 34316326
[TBL] [Abstract][Full Text] [Related]
3. Novel screen for anti-cancer drugs that elevate chromosome instability (CIN) using human artificial chromosome (HAC).
Kouprina N; Pommier Y; Larionov V
Oncotarget; 2018 Dec; 9(96):36833-36835. PubMed ID: 30627324
[TBL] [Abstract][Full Text] [Related]
4. A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cells.
Lee HS; Lee NC; Grimes BR; Samoshkin A; Kononenko AV; Bansal R; Masumoto H; Earnshaw WC; Kouprina N; Larionov V
BMC Cancer; 2013 May; 13():252. PubMed ID: 23694679
[TBL] [Abstract][Full Text] [Related]
5. Pt-ttpy, a G-quadruplex binding platinum complex, induces telomere dysfunction and G-rich regions DNA damage.
Ali S; Lombardi EP; Ghosh D; Jia T; Vitry G; Saker L; Poupon J; Teulade-Fichou MP; Nicolas A; Londono-Vallejo A; Bombard S
Metallomics; 2021 Jun; 13(6):. PubMed ID: 34021581
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
Liu R; Liu J; Wang S; Wang Y; Zhang T; Liu Y; Geng X; Wang F
Cell Death Dis; 2019 Jul; 10(7):527. PubMed ID: 31296842
[TBL] [Abstract][Full Text] [Related]
7. Crossroads of telomere biology and anticancer drug discovery.
Seimiya H
Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
[TBL] [Abstract][Full Text] [Related]
8. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
9. Potential Telomere-Related Pharmacological Targets.
Berei J; Eckburg A; Miliavski E; Anderson AD; Miller RJ; Dein J; Giuffre AM; Tang D; Deb S; Racherla KS; Patel M; Vela MS; Puri N
Curr Top Med Chem; 2020; 20(6):458-484. PubMed ID: 31916516
[TBL] [Abstract][Full Text] [Related]
10. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
[TBL] [Abstract][Full Text] [Related]
11. Effect of penclomedine (NSC-338720) on telomere fusions, chromatin blebbing, and cell viability with and without telomerase activity and abrogated p53 function.
Pandita TK; Benvenuto JA; Shay JW; Pandita RK; Rakovitch E; Geard CR; Antman KH; Newman RA
Biochem Pharmacol; 1997 Feb; 53(3):409-15. PubMed ID: 9065745
[TBL] [Abstract][Full Text] [Related]
12. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
Mueller S; Hartmann U; Mayer F; Balabanov S; Hartmann JT; Brummendorf TH; Bokemeyer C
Invest New Drugs; 2007 Dec; 25(6):519-24. PubMed ID: 17534576
[TBL] [Abstract][Full Text] [Related]
13. [Telomeres and telomerase, new targets for anticancer chemotherapy].
Riou JF; Morjani H; Trentesaux C
Ann Pharm Fr; 2006 Mar; 64(2):97-105. PubMed ID: 16568010
[TBL] [Abstract][Full Text] [Related]
14. Prospects for anti-neoplastic therapies based on telomere biology.
Stewart SA; Hahn WC
Curr Cancer Drug Targets; 2002 Mar; 2(1):1-17. PubMed ID: 12188917
[TBL] [Abstract][Full Text] [Related]
15. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
16. Methods of studying telomere damage induced by quadruplex-ligand complexes.
Rizzo A; Salvati E; Biroccio A
Methods; 2012 May; 57(1):93-9. PubMed ID: 22410593
[TBL] [Abstract][Full Text] [Related]
17. A human artificial chromosome recapitulates the metabolism of native telomeres in mammalian cells.
Wakai M; Abe S; Kazuki Y; Oshimura M; Ishikawa F
PLoS One; 2014; 9(2):e88530. PubMed ID: 24558398
[TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibitors for the treatment of cancer: the current perspective.
Perry PJ; Arnold JR; Jenkins TC
Expert Opin Investig Drugs; 2001 Dec; 10(12):2141-56. PubMed ID: 11772310
[TBL] [Abstract][Full Text] [Related]
19. Telomeres and telomerase: Pharmacological targets for new anticancer strategies?
Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E
Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
